SCHEMBL1711883

SCHEMBL1711883

O=C1CCC(NS(=O)(=O)c2ccccc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.56
KDM4E B2RXH2 1/20 0.56
RECQL P46063 1/20 0.56
PARG Q86W56 1/20 0.51
CTSB P07858 3/20 0.50
CTSK P43235 3/20 0.50
UCHL1 P09936 2/20 0.50
CTSS P25774 2/20 0.50
CTSC P53634 2/20 0.50
USP30 Q70CQ3 2/20 0.50
CTSL P07711 1/20 0.50
HTR1A P08908 1/20 0.49
HTR7 P34969 1/20 0.49
PSEN1 P49768 1/20 0.49
PSEN2 P49810 1/20 0.49
APH1B Q8WW43 1/20 0.49
NCSTN Q92542 1/20 0.49
APH1A Q96BI3 1/20 0.49
PSENEN Q9NZ42 1/20 0.49
MMP2 P08253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1711630 0.90 UCHL1 (0.54) SMN1; SMN2KDM4ERECQLPARGUCHL1
SCHEMBL9832398 0.90 PSEN1 (0.50) SMN1; SMN2KDM4ERECQLPARGCTSB
SCHEMBL8355420 0.87 KDM4E (0.67) SMN1; SMN2KDM4ERECQLPARGCTSB
SCHEMBL2225334 0.87 KDM4E (0.67) SMN1; SMN2KDM4ERECQLPARGCTSB
Hydrochloric Acid SCHEMBL15687975 0.85 KDM4E (0.64) SMN1; SMN2KDM4ERECQLPARGCTSB
SCHEMBL7648169 0.83 KDM4E (0.81) SMN1; SMN2KDM4ERECQLMMP2MMP9
SCHEMBL4041413 0.83 KDM4E (0.74) SMN1; SMN2KDM4ERECQLCTSBCTSK
SCHEMBL9594597 0.83 KDM4E (0.58) SMN1; SMN2KDM4ERECQLPARGUCHL1
SCHEMBL9832886 0.83 ALDH1A1 (0.71) SMN1; SMN2KDM4ERECQLPSEN1PSEN2
SCHEMBL9015380 0.83 KDM4E (0.58) SMN1; SMN2KDM4ERECQLHTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191483-A1 COMPOUNDS AS CRTH2 ANTAGONIST AND USES THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2017-07-19 EP disclosed
WO-2016037591-A1 COMPOUNDS AS CRTH2 ANTAGONIST AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-03-17 WO disclosed
EP-2344449-A1 ARYL-PHENYL-SULFONAMIDO-CYCLOALKYL COMPOUNDS AND THEIR USE Pimco 2664 Limited (GB) 2011-07-20 EP disclosed
EP-0242518-B1 Cycloalkano[1,2-b]indole-sulfonamides BAYER AG (DE) 1991-04-10 EP disclosed
US-4988820-A Inhibiting platelet aggregation, anticoagulants, thromboxane a2 antagonist BAYER AKTIENGESELLSCHAFT (DE) 1991-01-29 US disclosed
US-4965258-A Anticoagulant; thromboxane a2 antagonist BAYER AKTIENGESELLSCHAFT (DE) 1990-10-23 US disclosed
US-4904797-A REACTING A (BENZENESULFONAMIDOALKYL)CYCLOALKANO(1,2-B)INDOLE WITH ACRYLONITRILE; HYDROLYSIS, HYDROGENATION, REDUCTION BAYER AKTIENGESELLSCHAFT (DE) 1990-02-27 US disclosed
US-4827032-A INTERMEDIATES FOR ANTICOAGULANTS BAYER AKTIENGESELLSCHAFT (DE) 1989-05-02 US disclosed
EP-0242518-A1 Cycloalkano[1,2-b]indole-sulfonamides BAYER AG (DE) 1987-10-28 EP disclosed